Search by property
This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.
List of results
- Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis + (oral, 2x Placebo + 1000 U daily Vitamin E (2x 500 U) Start: +7 (± 4) years post-RTX Duration: 6 months)
- Kottschade et al. (2011): The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial + (oral, 2x daily, Start: during days 1-4 of chemotherapy Duration: until 1 month post-chemotherapy)
- Argyriou et al. (2006): Preventing Paclitaxel-Induced Peripheral neuropathy: A Phase 2 Trial of Vitamin E Supplementation + (oral, 300mg, 2x daily Duration: during chemotherapy until 3 months afterwards)
- Kottschade et al. (2011): The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial + (oral, 300mg, 2x daily, Start: during days 1-4 of chemotherapy Duration: until 1 month post-chemotherapy)
- Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis + (oral, 4x Placebo Start: +7 (± 4) years post-RTX Duration: 6 months)
- Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis + (oral, 800 mg daily Pentoxifyllin (2x 400 mg) + 1000 U daily Vitamin E (2x 500 U) Start: +7 (± 4) years post-RTX Duration: 6 months)
- Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis + (oral, 800 mg daily Pentoxifyllin (2x 400 mg) + 2x placebo Start: +7 (± 4) years post-RTX Duration: 6 months)
- Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors + (twice daily)